Stocks
Atara Biotherapeutics (ATRA) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -121.6% | -180.3% | 278.3% | 87.8% | -84.9% | 25.4% | ||
| Changes by years, y/y, % | -55pp | -59pp | +459pp | -190pp | -173pp | +5.1% | |||
Atara Biotherapeutics. ROE, %
Atara Biotherapeutics. ROE, changes, pp
Atara Biotherapeutics (ATRA) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 28.4% | -16.5% | -63.9% | -84.9% | 25.4% | 25.4% | |
| Changes by years, y/y, % | -209pp | -180pp | -211pp | -173pp | -3pp | |||
| Changes by quarters, q/q, % | -59pp | -45pp | -47pp | -21pp | +110pp | |||
